Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $3.04 USD
Change Today +0.09 / 3.05%
Volume 50.7K
BTX On Other Exchanges
BTX is not on other exchanges.
As of 1:52 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter S. Garcia

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 5 different industries.

As of Fiscal Year 2013


Mr. Peter S. Garcia, also known as Pete, has been the Chief Financial Officer and Vice President at PDL BioPharma, Inc. since May 13, 2013. Mr. Garcia served as the Chief Financial Officer and Principal Accounting Officer of Asterias Biotherapeutics, Inc. Mr. Garcia served as Acting Chief Accounting Officer of PDL BioPharma, Inc. from May 13, 2013 to July 24, 2013. He served as the Chief Financial Officer of BioTime, Inc. from October 4, 2011 to June 11, 2013 and also ...

Read Full Background

Corporate Headquarters*

1301 Harbor Bay Parkway
Alameda, California 94502

United States

Phone: 510-521-3390
Fax: 510-521-3389

Board Members Memberships*

There is no Board Members Memberships data available.


BA 1983
Stanford University
MBA 1985
UCLA Anderson School of Management

Other Affiliations*

Annual Compensation*

Total Annual Compensation$405,600

Stock Options*

Restricted Stock Awards$250,295
All Other Compensation$58,000

Total Compensation*

Total Annual Cash Compensation$1,464,268
Total Short Term Compensation$405,600
Other Long Term Compensation$308,295
Total Calculated Compensation$1,714,563
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BTX:US $3.04 USD +0.09


John W. Varian Chief Executive Officer and Director
XOMA Corporation
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
Tim Van Hauwermeiren MSc, EMBAChief Executive Officer and Executive Director
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTIME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at